Castrate Resistant Prostate Cancer Enhertu Therapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Use of Enhertu as a Subsequent Line of Therapy in HER2-Positive Metastatic Castration-Resistant Prostate Adenocarcinoma.
Epistemonikos ID: 49f66c364b125ba0c660222d02c050a12ee50311
First added on: Oct 01, 2024